LncRNA HIF1A-AS2 Promotes Osteosarcoma Progression by Acting As a Sponge of MiR-129-5p

Overview

Journal Aging (Albany NY)

Specialty Geriatrics

Date 2019 Dec 24

PMID 31866584

Citations 11

Authors

Xuesong Wang

Lei Peng

Xiaojin Gong

Xiugong Zhang

Ruifu Sun

Affiliations

Soon will be listed here.

Abstract

Increasing studies have demonstrated that long noncoding RNAs (lncRNAs) play vital roles in tumor development and progression. However, the relationship between osteosarcoma and HIF1AAS2 remains unknown. The expression of HIF1AAS2 and miR-129-5p was detected in osteosarcoma cell lines and samples via qRT-PCR. Cell Counting Kit-8 (CCK-8) and invasion assays were performed to determine cell proliferation and invasion ability, and a dual luciferase reporter assay was performed to determine the interaction between HIF1AAS2 and miR-129-5p. We showed that the expression of HIF1A-AS2 was upregulated in the osteosarcoma samples compared with the expression in noncancerous samples. Moreover, patients with high HIF1A-AS2 expression had a shorter overall survival. Ectopic expression of HIF1A-AS2 enhanced osteosarcoma cell proliferation, cell cycle progression and invasion. We found that overexpression of miR-129-5p decreased the luciferase activity of wild-type (WT) HIF1A-AS2 but not mutant HIF1A-AS2. Ectopic expression of HIF1A-AS2 suppressed miR-129-5p expression in MG-63 cells. We demonstrated that miR-129-5p was downregulated in osteosarcoma and was negatively associated with HIF1A-AS2 expression. Furthermore, ectopic expression of miR-129-5p suppressed osteosarcoma cell proliferation, cell cycle progression and invasion. In addition, overexpression of HIF1A-AS2 promoted cell proliferation, cell cycle progression and invasion of osteosarcoma cells through the modulation of miR-129-5p. These results indicated that HIF1A-AS2 might be a potential therapeutic target for osteosarcoma.

Citing Articles

Comprehensive analysis of ESCRT transcriptome-associated signatures and identification of the regulatory role of LMO7-AS1 in osteosarcoma.

Zhao S, Tian D, Huang F, Wang L, Cheng J, He Z Cancer Cell Int. 2025; 25(1):29.

PMID: 39885569 PMC: 11783933. DOI: 10.1186/s12935-025-03659-4.

Long non-coding RNA HIF1A-As2 and MYC form a double-positive feedback loop to promote cell proliferation and metastasis in KRAS-driven non-small cell lung cancer.

Yang K, Zhang W, Zhong L, Xiao Y, Sahoo S, Fassan M Cell Death Differ. 2023; 30(6):1533-1549.

PMID: 37041291 PMC: 10089381. DOI: 10.1038/s41418-023-01160-x.

LncRNAs could play a vital role in osteosarcoma treatment: Inhibiting osteosarcoma progression and improving chemotherapy resistance.

Xiaotong S, Xiao L, Shiyu L, Zhiguo B, Chunyang F, Jianguo L Front Genet. 2023; 13:1022155.

PMID: 36726721 PMC: 9885180. DOI: 10.3389/fgene.2022.1022155.

A novel regulated network mediated by downregulation lncRNA impairs placental angiogenesis by promoting ANGPTL4 expression in preeclampsia.

Shu L, Wang C, Ding Z, Tang J, Zhu Y, Wu L Front Cell Dev Biol. 2022; 10:837000.

PMID: 36016656 PMC: 9396278. DOI: 10.3389/fcell.2022.837000.

HIF1A-AS2 induces osimertinib resistance in lung adenocarcinoma patients by regulating the miR-146b-5p/IL-6/STAT3 axis.

Si J, Ma Y, Lv C, Hong Y, Tan H, Yang Y Mol Ther Nucleic Acids. 2021; 26:613-624.

PMID: 34703647 PMC: 8517096. DOI: 10.1016/j.omtn.2021.09.003.

References

Li L, Wang M, Mei Z, Cao W, Yang Y, Wang Y . lncRNAs HIF1A-AS2 facilitates the up-regulation of HIF-1α by sponging to miR-153-3p, whereby promoting angiogenesis in HUVECs in hypoxia. Biomed Pharmacother. 2017; 96:165-172. DOI: 10.1016/j.biopha.2017.09.113. View

Wang L, Lin Y, Meng H, Liu C, Xue J, Zhang Q . Long non-coding RNA LOC283070 mediates the transition of LNCaP cells into androgen-independent cells possibly via CAMK1D. Am J Transl Res. 2017; 8(12):5219-5234. PMC: 5209477. View

Deng L, Yang S, Xu F, Zhang J . Long noncoding RNA CCAT1 promotes hepatocellular carcinoma progression by functioning as let-7 sponge. J Exp Clin Cancer Res. 2015; 34:18. PMC: 4339002. DOI: 10.1186/s13046-015-0136-7. View

Liu C, Lin J . Long noncoding RNA ZEB1-AS1 acts as an oncogene in osteosarcoma by epigenetically activating ZEB1. Am J Transl Res. 2016; 8(10):4095-4105. PMC: 5095304. View

You B, Park W . Suberoylanilide hydroxamic acid induces thioredoxin1-mediated apoptosis in lung cancer cells via up-regulation of miR-129-5p. Mol Carcinog. 2017; 56(12):2566-2577. DOI: 10.1002/mc.22701. View

Feldstein O, Ben-Hamo R, Bashari D, Efroni S, Ginsberg D . RBM38 is a direct transcriptional target of E2F1 that limits E2F1-induced proliferation. Mol Cancer Res. 2012; 10(9):1169-77. DOI: 10.1158/1541-7786.MCR-12-0331. View

Xin Y, Li Z, Shen J, Chan M, Wu W . CCAT1: a pivotal oncogenic long non-coding RNA in human cancers. Cell Prolif. 2016; 49(3):255-60. PMC: 6496795. DOI: 10.1111/cpr.12252. View

Li Z, Yu X, Shen J . Long non-coding RNAs: emerging players in osteosarcoma. Tumour Biol. 2016; 37(3):2811-6. DOI: 10.1007/s13277-015-4749-4. View

Yu Y, Yang J, Li Q, Xu B, Lian Y, Miao L . LINC00152: A pivotal oncogenic long non-coding RNA in human cancers. Cell Prolif. 2017; 50(4). PMC: 6529135. DOI: 10.1111/cpr.12349. View

10.

Zhu H, Li X, Song Y, Zhang P, Xiao Y, Xing Y . Long non-coding RNA ANRIL is up-regulated in bladder cancer and regulates bladder cancer cell proliferation and apoptosis through the intrinsic pathway. Biochem Biophys Res Commun. 2015; 467(2):223-8. DOI: 10.1016/j.bbrc.2015.10.002. View

11.

Hughes D . How the NOTCH pathway contributes to the ability of osteosarcoma cells to metastasize. Cancer Treat Res. 2010; 152:479-96. DOI: 10.1007/978-1-4419-0284-9_28. View

12.

Li Z, Shen J, Chan M, Wu W . MicroRNA-379 suppresses osteosarcoma progression by targeting PDK1. J Cell Mol Med. 2016; 21(2):315-323. PMC: 5264134. DOI: 10.1111/jcmm.12966. View

13.

Chen M, Zhuang C, Liu Y, Li J, Dai F, Xia M . Tetracycline-inducible shRNA targeting antisense long non-coding RNA HIF1A-AS2 represses the malignant phenotypes of bladder cancer. Cancer Lett. 2016; 376(1):155-64. DOI: 10.1016/j.canlet.2016.03.037. View

14.

Li Z, Shen J, Chan M, Wu W . TUG1: a pivotal oncogenic long non-coding RNA of human cancers. Cell Prolif. 2016; 49(4):471-5. PMC: 6496395. DOI: 10.1111/cpr.12269. View

15.

Long X, Zhou Y, Peng A, Zhang Z, Chen X, Chen W . Demethylation-mediated miR-129-5p up-regulation inhibits malignant phenotype of osteogenic osteosarcoma by targeting Homo sapiens valosin-containing protein (VCP). Tumour Biol. 2015; 36(5):3799-806. DOI: 10.1007/s13277-014-3021-7. View

16.

Tang J, Shen L, Yang Q, Zhang C . Overexpression of metadherin mediates metastasis of osteosarcoma by regulating epithelial-mesenchymal transition. Cell Prolif. 2014; 47(5):427-34. PMC: 6495483. DOI: 10.1111/cpr.12129. View

17.

Li J, Lian Y, Yan C, Cai Z, Ding J, Ma Z . Long non-coding RNA FOXP4-AS1 is an unfavourable prognostic factor and regulates proliferation and apoptosis in colorectal cancer. Cell Prolif. 2016; 50(1). PMC: 6529074. DOI: 10.1111/cpr.12312. View

18.

Huang G, Nishimoto K, Yang Y, Kleinerman E . Participation of the Fas/FasL signaling pathway and the lung microenvironment in the development of osteosarcoma lung metastases. Adv Exp Med Biol. 2014; 804:203-17. DOI: 10.1007/978-3-319-04843-7_11. View

19.

Liu K, Huang J, Ni J, Song D, Ding M, Wang J . MALAT1 promotes osteosarcoma development by regulation of HMGB1 via miR-142-3p and miR-129-5p. Cell Cycle. 2017; 16(6):578-587. PMC: 5384591. DOI: 10.1080/15384101.2017.1288324. View

20.

Chen W, Huang M, Kong R, Xu T, Zhang E, Xia R . Antisense Long Noncoding RNA HIF1A-AS2 Is Upregulated in Gastric Cancer and Associated with Poor Prognosis. Dig Dis Sci. 2015; 60(6):1655-62. DOI: 10.1007/s10620-015-3524-0. View